Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · IEX Real-Time Price · USD
3.450
+0.040 (1.17%)
At close: Jul 19, 2024, 4:00 PM
3.600
+0.150 (4.35%)
Pre-market: Jul 22, 2024, 8:00 AM EDT
Avenue Therapeutics Employees
Avenue Therapeutics had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$2,393,667
Market Cap
3.25M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Aditxt | 47 |
Aptevo Therapeutics | 40 |
Healthcare Triangle | 31 |
Petros Pharmaceuticals | 21 |
Ensysce Biosciences | 7 |
ZyVersa Therapeutics | 7 |
CNS Pharmaceuticals | 5 |
Qualigen Therapeutics | 4 |
ATXI News
- 4 weeks ago - Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 2 months ago - Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) - GlobeNewsWire
- 2 months ago - Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 3 months ago - Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds - GlobeNewsWire
- 3 months ago - Avenue Therapeutics Announces Reverse Stock Split - GlobeNewsWire
- 4 months ago - Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024 - GlobeNewsWire
- 4 months ago - Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 months ago - Avenue Therapeutics Receives Positive Listing Determination from Nasdaq - GlobeNewsWire